Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/17018619

Cancer Res. 2006 Oct 1 66 19 9617-24

Download in:

View as

General Info

PMID
17018619